Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1994 | 03-1994 | 12-1993 | 09-1993 | 12-1992 | |
| Operating Expenses | 612 | 682 | 0 | 355 | 0 |
| Operating Income | -612 | -682 | N/A | -355 | N/A |
| Other Income | 74 | 66 | 0 | 13 | 0 |
| Pre-tax Income | -538 | -616 | 0 | -342 | 0 |
| Net Income Continuous | -538 | -616 | N/A | -342 | N/A |
| Net Income | $-538 | $-616 | $N/A | $-342 | $N/A |
| EPS Basic Total Ops | -25.50 | -29.76 | N/A | -16.85 | N/A |
| EPS Basic Continuous Ops | -25.50 | -29.76 | N/A | -16.85 | N/A |
| EPS Diluted Total Ops | -25.50 | -29.76 | N/A | -16.85 | N/A |
| EPS Diluted Continuous Ops | -25.50 | -29.76 | N/A | -16.85 | N/A |
| EBITDA(a) | $-612 | $-682 | $N/A | $-355 | $N/A |